Remove Government Remove Treatment Remove Virus
article thumbnail

COVID-19 patients are experiencing long-term effects from the virus

The Pharma Data

A further 21% of 1,030 doctors who had since recovered from the virus reported chronic fatigue, while 11% said they had no concentration difficulties. Until this is known, it is imperative that the Government and the NHS does more to protect the medical community from infection. Conor Kavanagh. Source link.

Virus 52
article thumbnail

Antibody Treatment Approved for Emergency Use Against Early COVID-19

The Pharma Data

Antibody Treatment Approved for Emergency Use Against Early COVID-19. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. Instead, the treatment should be given as soon as possible after a positive test and within 10 days of developing symptoms. government.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moderna says its COVID-19 vaccine shows promise in elderly patients

The Pharma Data

The company has already tested the treatment on 10 adults between the ages of 56-70, and 10 over 71. These antibodies were higher than those seen in people who had recovered from the virus. Earlier this month, the US Government announced that it would purchase 100 million doses of the Moderna vaccine in a deal worth $1.53

Vaccine 90
article thumbnail

Oyagen, Inc. Publishes Study On Its OYA1 As A “Highly Effective” Experimental Drug Candidate For Treating Infections By The Ebola Virus

The Pharma Data

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.’ The published study results showed that OYA1 was “highly effective” in reducing the spread of Ebola Virus infection in laboratory tests with the live Ebola virus carried out by NIAID.

Virus 40
article thumbnail

Gilead applies for FDA approval to treat coronavirus patients with remdesivir

The Pharma Data

The treatment is already available on an emergency basis for people suffering with severe symptoms from coronavirus. It has not received general approval to treat the virus in the US, but has in several European countries and Japan. Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients.

article thumbnail

Coronavirus: 'Long Covid' patients need treatment programme, doctors say

The Pharma Data

‘I just want my life back’ The government moved away from community testing on 12 March, instead only testing those admitted to hospital. The government is simply not doing enough with the existing medical expertise. However, many of these people may not have been tested for Covid. ” Person-centred rehab.

Doctors 52
article thumbnail

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

The Pharma Data

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication of SARS-CoV-2, the virus that causes COVID-19.